First line treatment of adult patients with primary immune thrombocytopenia: a real-world study
Immune thrombocytopenia (ITP) is an autoimmune disease with a mild to severe risk of bleeding complications. First line treatment includes corticosteroids, immunoglobulins, or other. In this large cohort study, first-line strategies for treatment-naive adult primary ITP was studied in a real-world s...
Main Authors: | Liang Wang, Lei Xu, Hongyuan Hao, A. J. Gerard Jansen, Guoqiang Liu, Honglei Li, Xinguang Liu, Yajing Zhao, Jun Peng, Ming Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2019.1572875 |
Similar Items
-
The association between platelet glycoprotein-specific antibodies and response to short-term high-dose dexamethasone with prednisone maintenance treatment in adult patients with primary immune thrombocytopenia
by: Yan-Qiu Hou, et al.
Published: (2022-12-01) -
Effectiveness of Various Treatments for Sudden Sensorineural Hearing Loss—A Retrospective Study
by: Magdalena B. Skarżyńska, et al.
Published: (2022-01-01) -
Evaluation of treatment plan by three-period pulses of high-dose dexamethasone among patients with primary immune thrombocytopenia on platelet count response and adverse events: A randomized Clinical trial
by: Alireza Sadeghi, et al.
Published: (2020-01-01) -
Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United States
by: Adam Cuker, et al.
Published: (2023-05-01) -
The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity
by: Eman Mostafa Hamed, et al.
Published: (2023-06-01)